Cardiology
VKA monotherapy linked to reduced MI, stroke risk in A-fib
(HealthDay)—For patients with atrial fibrillation (AF), vitamin K antagonist (VKA) monotherapy is associated with reduced risk of first-time myocardial infarction (MI) and stroke compared with acetylsalicylic acid (ASA) ...
Jun 20, 2017
0
1
